Mevastatin increases eNO synthase expression and inhibits lipid peroxidation in human endothelial cells

Clinical Hemorheology and Microcirculation

Volumn 37, Issue 1-2, 2007, Pages 179-184

  Schalkwijk, Casper G ^a,b   Van Dam, Bastiaan ^a   Stehouwer, Coen D A ^b   Van Hinsbergh, Victor W M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; MEVALONIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIGEN EXPRESSION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME MODIFICATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LOVASTATIN; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; UMBILICAL VEINS;

EID: 34347334674     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. C.G. Schalkwijk and C.D. Stehouwer, Vascular complications in diabetes mellitus: the role of endothelial dysfunction, Clin. Sci. (Lond.) 109 (2005), 143-159.
2. C.J. Vaughan and A.M. Gotto, Jr., Update on statins: 2003, Circulation 110 (2004), 886-892.
3. C.P. Sparrow, C.A. Burton, M. Hernandez, S. Mundt, H. Hassing, S. Patel, R. Rosa, A. Hermanowski-Vosatka, P.R. Wang, D. Zhang, L. Peterson, P.A. Detmers, Y.S. Chao and S.D. Wright, Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering, Arterioscler. Thromb. Vasc. Biol. 21 (2001), 115-121.
4. J.K. Liao and U. Laufs, Pleiotropic effects of statins, Annu. Rev. Pharmacol. Toxicol. 45 (2005), 89-118.
5. M. Eto and T.F. Luscher, The cardioprotective effects of statins, Coron. Artery Dis. 15 (2004), 243-245.
6. U. Laufs, F. La, V.J. Plutzky and J.K. Liao, Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors, Circulation 97 (1998), 1129-1135.
7. J. Haendeler, J. Hoffmann, A.M. Zeiher and S. Dimmeler, Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins, Circulation 110 (2004), 856-861.
8. M.J. Haas, M.H. Horani, S.A. Parseghian and A.D. Mooradian, Statins prevent dextrose-induced endothelial barrier dysfunction, possibly through inhibition of superoxide formation, Diabetes 55 (2006), 474-479.
9. R.P. Mason, M.F. Walter and R.F. Jacob, Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress, Circulation 109 (2004), II34-II41.
10. C.G. Schalkwijk, M.A. Vermeer, C.D. Stehouwer, K.J. te, H.M. Princen and V.W. van Hinsbergh, Effect of methylglyoxal on the physico-chemical and biological properties of low-density lipoprotein, Biochim. Biophys. Acta 1394 (1998), 187-198.
11. B. van Dam, V.W. van Hinsbergh, C.D. Stehouwer, A. Versteilen, H. Dekker, R. Buytenhek, H.M. Princen and C.G. Schalkwijk, Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjects, Cardiovasc. Res. 57 (2003), 563-571.
12. O. Hernandez-Perera, D. Perez-Sala, J. Navarro-Antolin, R. Sanchez-Pascuala, G. Hernandez, C. Diaz and S. Lamas, Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells, J. Clin. Invest. 101 (1998), 2711-2719.
13. Y. Rikitake and J.K. Liao, Rho GTPases, statins, and nitric oxide, Circ. Res. 97 (2005), 1232-1235.
14. R. De Caterina, P. Libby, H.B. Peng, V.J. Thannickal, T.B. Rajavashisth, M.A. Gimbrone, Jr., W.S. Shin and J.K. Liao, Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines, J. Clin. Invest. 96 (1995), 60-68.
15. S.H. Wilson, R.D. Simari, P.J. Best, T.E. Peterson, L.O. Lerman, M. Aviram, K.A. Nath, D.R. Holmes, Jr. and A. Lerman, Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering, Arterioscler. Thromb. Vasc. Biol. 21 (2001), 122-128.